Literature DB >> 19034644

Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.

Ellen T Chang1, Roger L Milne, Kelly-Anne Phillips, Jane C Figueiredo, Meera Sangaramoorthy, Theresa H M Keegan, Irene L Andrulis, John L Hopper, Pamela J Goodwin, Frances P O'Malley, Nayana Weerasooriya, Carmel Apicella, Melissa C Southey, Michael L Friedlander, Graham G Giles, Alice S Whittemore, Dee W West, Esther M John.   

Abstract

Although having a family history of breast cancer is a well established breast cancer risk factor, it is not known whether it influences mortality after breast cancer diagnosis. We studied 4,153 women with first primary incident invasive breast cancer diagnosed between 1991 and 2000, and enrolled in the Breast Cancer Family Registry through population-based sampling in Northern California, USA; Ontario, Canada; and Melbourne and Sydney, Australia. Cases were oversampled for younger age at diagnosis and/or family history of breast cancer. Carriers of germline mutations in BRCA1 or BRCA2 were excluded. Cases and their relatives completed structured questionnaires assessing breast cancer risk factors and family history of cancer. Cases were followed for a median of 6.5 years, during which 725 deaths occurred. Cox proportional hazards regression was used to evaluate associations between family history of breast cancer at the time of diagnosis and risk of all-cause mortality after breast cancer diagnosis, adjusting for established prognostic factors. The hazard ratios for all-cause mortality were 0.98 (95% confidence interval [CI] = 0.84-1.15) for having at least one first- or second-degree relative with breast cancer, and 0.85 (95% CI = 0.70-1.02) for having at least one first-degree relative with breast cancer, compared with having no such family history. Estimates did not vary appreciably when stratified by case or tumor characteristics. In conclusion, family history of breast cancer is not associated with all-cause mortality after breast cancer diagnosis for women without a known germline mutation in BRCA1 or BRCA2. Therefore, clinical management should not depend on family history of breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19034644      PMCID: PMC2728159          DOI: 10.1007/s10549-008-0255-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  43 in total

1.  Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.

Authors:  Irene L Andrulis; Hoda Anton-Culver; Jeanne Beck; Betsy Bove; Jeff Boyd; Saundra Buys; Andrew K Godwin; John L Hopper; Frederick Li; Susan L Neuhausen; Hilmi Ozcelik; David Peel; Regina M Santella; Melissa C Southey; Nathalie J van Orsouw; Deon J Venter; Jan Vijg; Alice S Whittemore
Journal:  Hum Mutat       Date:  2002-07       Impact factor: 4.878

2.  The emerging landscape of breast cancer susceptibility.

Authors:  Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2008-01       Impact factor: 38.330

3.  Breast-conservation therapy in early-stage breast cancer patients with a positive family history.

Authors:  Georges Vlastos; Nadeem Q Mirza; Funda Meric; Kelly K Hunt; Attiqa N Mirza; Lisa A Newman; Frederick C Ames; Henry M Kuerer; Merrick I Ross; Barry Feig; Gildy Babiera; Thomas A Buchholz; Gabriel N Hortobagyi; S Eva Singletary
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

4.  Preventive health behaviors and familial breast cancer.

Authors:  Lisa Madlensky; Robert A Vierkant; Celine M Vachon; V Shane Pankratz; James R Cerhan; Susan Thomas Vadaparampil; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

5.  Does family history influence survival in breast cancer cases?

Authors:  Antonio Russo; Andrea Herd-Smith; Donella Gestri; Simonetta Bianchi; Vanna Vezzosi; Marco Rosselli Del Turco; Gaetano Cardona
Journal:  Int J Cancer       Date:  2002-05-20       Impact factor: 7.396

6.  Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

Authors:  Neesha Rodrigues; Darryl Carter; Deborah Dillon; Nicole Parisot; Doo Ho Choi; Bruce G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-12-01       Impact factor: 7.038

7.  Family breast cancer history and mammography: Framingham Offspring Study.

Authors:  J M Murabito; J C Evans; M G Larson; B E Kreger; G L Splansky; K M Freund; M A Moskowitz; P W Wilson
Journal:  Am J Epidemiol       Date:  2001-11-15       Impact factor: 4.897

8.  Prognosis of breast cancer patients with familial history classified according to their menopausal status.

Authors:  Takayuki Kinoshita; Takashi Fukutomi; Eriko Iwamoto; Sadako Akashi-Tanaka
Journal:  Breast J       Date:  2004 May-Jun       Impact factor: 2.431

9.  Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.

Authors:  Andrea Veronesi; Clelia de Giacomi; Maria D Magri; Davide Lombardi; Martina Zanetti; Cristina Scuderi; Riccardo Dolcetti; Alessandra Viel; Diana Crivellari; Ettore Bidoli; Mauro Boiocchi
Journal:  BMC Cancer       Date:  2005-07-04       Impact factor: 4.430

10.  Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.

Authors: 
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

View more
  8 in total

1.  Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry.

Authors:  Theresa H M Keegan; Roger L Milne; Irene L Andrulis; Ellen T Chang; Meera Sangaramoorthy; Kelly-Anne Phillips; Graham G Giles; Pamela J Goodwin; Carmel Apicella; John L Hopper; Alice S Whittemore; Esther M John
Journal:  Breast Cancer Res Treat       Date:  2010-02-07       Impact factor: 4.872

2.  Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer.

Authors:  Kathleen E Malone; Janet R Daling; David R Doody; Cecilia O'Brien; Alexa Resler; Elaine A Ostrander; Peggy L Porter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

Review 3.  The association between prognosis of breast cancer and first-degree family history of breast or ovarian cancer: a systematic review and meta-analysis.

Authors:  Jun-Long Song; Chuang Chen; Jing-Ping Yuan; Sheng-Rong Sun
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

4.  Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry.

Authors:  Kelly-Anne Phillips; Roger L Milne; Dee W West; Pamela J Goodwin; Graham G Giles; Ellen T Chang; Jane C Figueiredo; Michael L Friedlander; Theresa H M Keegan; Gord Glendon; Carmel Apicella; Frances P O'Malley; Melissa C Southey; Irene L Andrulis; Esther M John; John L Hopper
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

5.  Meanings of abortion in context: accounts of abortion in the lives of women diagnosed with breast cancer.

Authors:  Maggie Kirkman; Carmel Apicella; Jillian Graham; Martha Hickey; John L Hopper; Louise Keogh; Ingrid Winship; Jane Fisher
Journal:  BMC Womens Health       Date:  2017-04-05       Impact factor: 2.809

6.  Second primary cancer after female breast cancer: Familial risks and cause of death.

Authors:  Guoqiao Zheng; Akseli Hemminki; Asta Försti; Jan Sundquist; Kristina Sundquist; Kari Hemminki
Journal:  Cancer Med       Date:  2018-11-26       Impact factor: 4.452

7.  Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients.

Authors:  Hassan Jouhadi; Amal Tazzite; Houssine Azeddoug; Asmâa Naim; Sellama Nadifi; Abdellatif Benider
Journal:  BMC Res Notes       Date:  2016-04-29

8.  Family history of breast cancer and its association with disease severity and mortality.

Authors:  Jennifer C Melvin; Wahyu Wulaningsih; Zac Hana; Arnie D Purushotham; Sarah E Pinder; Ian Fentiman; Cheryl Gillett; Anca Mera; Lars Holmberg; Mieke Van Hemelrijck
Journal:  Cancer Med       Date:  2016-01-22       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.